Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer hails hepatitis C candidate

November 9, 2011
Sales and Marketing BI201335, Boehringer Ingelheim, HCV, Incivo, Victrelis, hepatitis C

Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …

News
Roche pic

Roche’s skin cancer drug receives FDA priority review

November 9, 2011
Research and Development, Sales and Marketing Roche, vismodegib

Roche’s skin cancer pill vismodegib will receive a priority review from the FDA which could see it approved within six …

News

Autoclave Design Flexibility is Feature of Priorclave Stand at Medica1

November 9, 2011
Manufacturing and Production

Visitors to the Priorclave stand 1E02 can evaluate first-hand the benefits of models including: 

News
Press release

Timothy Wright appointed as global head of development at Novartis Pharmaceuticals

November 9, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis has appointed Dr Timothy Wright as the new global head of development of its pharmaceuticals business, effective immediately.  Dr …

Appointment

Pharma manufacturing news in brief

November 9, 2011
Manufacturing and Production manufacturing and production news

Nephron earmarks $313m for new US facility, police break up a demonstration at Dr Reddy’s with tear gas, plus updates …

News

‘Military-inspired’ project wins 2011 Facility of the Year Award

November 9, 2011
Manufacturing and Production MedImmune, manufacturing and production

MedImmune’s US manufacturing plant in Frederick, Maryland, has won the 2011 Facility of the Year Award, beating out rival category …

News

Edge Medical Communications makes two senior appointments

November 9, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edge Medical, Medical comms

Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …

Appointment
Lilly HQ picture

Amylin to pay up to $1.6 billion to sever ties with Lilly

November 8, 2011
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, R&D, lilly

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …

News

Strategic alliance executives

November 8, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTPartners, Strategic alliance executives

Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …

Feature

AZ and Targacept’s novel depression drug misses target

November 8, 2011
Research and Development, Sales and Marketing AstraZeneca

AstraZeneca and Targacept’s next generation depression drug has failed to meet its primary endpoint in a late-stage trial. The first …

News

UK pharma downbeat on its future – survey

November 8, 2011
Research and Development ABPI, R&D, VBP, rsa

The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …

News

Organising a successful event

November 8, 2011
Sales and Marketing

Company conferences and events have come a long way since we used to be taken out for a short meeting …

Feature
Thought Leadership

Market access – looking back

November 8, 2011
Sales and Marketing

Market access is complicated. Multifaceted, multi-discipline, multidimensional, multi-stake-holder, all these multiples make Market Access one of the most challenging and …

Feature
Thought Leadership

Daniel Grau appointed as president of Heptares

November 8, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares

Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors.  Mr Grau has been a …

Appointment
Pfizer Sandwich image

Pfizer to retain an extra 300 jobs at Sandwich site

November 8, 2011
Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich

Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …

News

TranslatePharma now partnered with European Regulatory Solutions

November 8, 2011

As a part of the ERA Consultancy Group, European Regulatory Solutions (ERS) specialise in offering consultancy services and regulatory advice …

News
Press release

GSK taps Alnylam tech for vaccine production

November 7, 2011
Manufacturing and Production, Sales and Marketing Alnylam, GSK, vaccines

GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …

News

Bosch planning second packaging plant in China

November 7, 2011
Manufacturing and Production Bosch, China

Bosch Packaging Technology has decided to boost its presence in Asia with the construction of a second plant in the …

News

Contract research news in brief

November 7, 2011
Manufacturing and Production

No new suitors come forward for PPD, Icon and Charles River report mixed Q3 results, plus updates from Cyprotex and …

News
david_roblin__picture_o

Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma

November 7, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D

Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …

Appointment
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026